Tag: Oticon Medical

All

Latest

Widex Appoints Alan Raffauf as VP of Marketing

Alan Raffauf comes to Widex from Oticon Medical, where since 2009, he served as Vice President of Marketing with responsibility for the go-to-market readiness and lifecycle management of bone-anchored hearing products and cochlear implants for the United States and Canada.

All

Latest

Demant Recalls Non-implanted Neuro Zti Implants

Oticon Medical, which constitutes the hearing implants business in the Demant Group, announced that it has decided to take voluntary field corrective action by recalling non-implanted Oticon Medical Neuro Zti implants and to temporarily halt sales of new implants. The recall is entirely related to the identification of performance issues in a small subset of implants, and there have been no reported safety events with the implants, according to the company's announcement.

Two New Bone-anchored Implant Products Gain FDA Clearance

The FDA has cleared two new Oticon Medical products for marketing in the US: The Minimally Invasive Ponto Surgery (MIPS), an update of the tissue preservation surgery for use with the company’s Ponto System; and the Ponto BHX Implant, which has a laser-ablated titanium surface that promotes a faster and stronger bonding to bone, and is designed to increase the strength of the bone-to-implant interface by more than 150%.

Read More

Oticon Medical Appoints Jared Schnackenberg as President US

Oticon Medical announced the appointment of Jared Schnackenberg as president of Oticon Medical US. He will provide overall leadership for the entire US organization to further develop Oticon Medical’s position in the bone anchored hearing solutions (BAHS) market and to prepare for the anticipated launch of Oticon Medical Cochlear Implants for the US market.

Read More
Loading